Newsletter Archive

11. 02.04.26 -- TFF Offers Ideal Anaerobic, GMP Conditions For LBP Concentration 2/4/2026
    02/04/26 Bioprocess Online Newsletter
12. 02.03.26 -- December 2025 — CDMO Opportunities And Threats Report 2/3/2026
    02/03/26 Bioprocess Online Newsletter
13. 02.02.26 -- Here's A Thought: What If Gene Editing Didn't Use Bacterial Enzymes? 2/2/2026
    02/02/26 Bioprocess Online Newsletter
14. 01.30.26 -- Managing Supply Chain Risk In Scale-Up And Multisite Trials 1/30/2026
    01/30/26
15. 01.30.26 -- STREAM Edition: How ADC Design Impacts CMC Development 1/30/2026

    01/30/26 Bioprocess Online Newsletter

16. 01.29.26 -- Mind The Potent Compounds When Retrofitting Facilities For ADCs 1/29/2026
    01/29/26
17. 01.28.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation? 1/28/2026
    01/28/26 Bioprocess Online Newsletter
18. 01.27.26 -- A Deeper Look At Pharma's Structural Supply Chain Vulnerability 1/27/2026
    01/27/26 Bioprocess Online Newsletter
19. 01.26.26 -- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches 1/26/2026
    01/26/26 Bioprocess Online Newsletter
20. 01.23.26 -- STREAM Edition: How To Strategically Integrate New Technology Into Existing Workflows 1/23/2026

    01/23/26 Bioprocess Online Newsletter